“…However, in the case of RA, FLS cells display pleomorphic changes and undergo tumor like proliferation, giving it an aggressive phenotype leading to inflammation, joint destruction, and pannus formation (Turner & Filer, ). Under inflammatory micro‐environment, RA‐FLS majorly secrete inflammatory cytokines (TNFα, IL‐1β, and IL‐6), inflammatory mediators (COX‐2 and iNOS) and effector molecules (RANKL, GM‐CSF, and IL‐23) (Asif Amin, Fox, & Ruth, ; Bustamante et al, ). Various cytokines synergistically promote the proliferation and survival of RA‐FLS cells in the synovium (Rockel & Kapoor, ).…”